."Patrys has secured a manufacturing slot with its CDMO for Q1 CY2024. This GMP (Good
Manufacturing Practice) production run is anticipated to complete around the end of Q1 CY2024 with final product
characterisation and quality verification expected during Q2 CY2024.
Q1CY24 ends 31 March 2024. Q2 CY24 end 30 June 2024.
We are 1 month away from hearing the resukt of the CDMO work and then just 3 more months to know if we are heading for the clinical trials?
This ship will leak, all bios do, so, we can start looking very closely at trading activity, probably, starting now. It will stick out like the proverbials.
How stiff were PABO and PABOA holders in 2023???!!! And all caused by an outside contractor (who should have been sued out of business, not given more!!!)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 154590723 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 55843936 | 26 |
View Market Depth
| Last trade - 16.26pm 29/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable